XCUR Q2 2022 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue LARK Q1 2026 Earnings EPS of 083 Amidst Stock Decline EE Q1 2026 Earnings EPS Misses Estimates Stock Gains 213 Arcturus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Pipeline Progress Continues SLB Q1 2026 Earnings EPS Slightly Misses Estimates Amid Stable Operations FIX Q1 2026 Earnings Massive EPS Beat Drives Strong Performance Despite Revenue Data Gap